Literature DB >> 22665602

The effect of removing potentially infectious dogs on the numbers of canine Leishmania infantum infections in an endemic area with high transmission rates.

Gabriel Grimaldi1, Antonio Teva, Claudiney B Santos, Adelson L Ferreira, Aloísio Falqueto.   

Abstract

To assess the effect of the rapid removal of potentially infectious dogs on the prevalence and incidence of canine infections, a prospective study was undertaken in an area endemic for Leishmania infantum. We used serological testing based on the rapid DPP rK28 fusion protein chromatographic immunoassay for this dog screening-and-culling intervention trial. The outcome was evaluated by measuring seropositivity and sero-conversion/-reversion rates for canine infection. Our estimates indicated that concomitant detection and elimination of seropositive dogs with active disease may affect the numbers of canine infections and disease burden temporarily, although it is insufficient as a measure to interrupt the zoonotic L. infantum transmission. However, most of the asymptomatic, seropositive dogs continuously exhibit low levels of antibodies and/or reverted, remaining seronegative thereafter. In the process of waiting for an effective vaccine, one option for canine reservoir control may be to identify these possibly genetically resistant animals and promote their expansion in the population.

Entities:  

Mesh:

Year:  2012        PMID: 22665602      PMCID: PMC3366541          DOI: 10.4269/ajtmh.2012.12-0040

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  43 in total

1.  Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective.

Authors:  C Bern; A B Joshi; S N Jha; M L Das; A Hightower; G D Thakur; M B Bista
Journal:  Am J Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.345

Review 2.  Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Authors:  François Chappuis; Shyam Sundar; Asrat Hailu; Hashim Ghalib; Suman Rijal; Rosanna W Peeling; Jorge Alvar; Marleen Boelaert
Journal:  Nat Rev Microbiol       Date:  2007-11       Impact factor: 60.633

3.  Canine visceral leishmaniasis in Teresina, Brazil: Relationship between clinical features and infectivity for sand flies.

Authors:  Maria Regiane Araújo Soares; Ivete Lopes de Mendonça; Jailon Moreira do Bonfim; José Alves Rodrigues; Guilherme Loureiro Werneck; Carlos Henrique Nery Costa
Journal:  Acta Trop       Date:  2010-09-15       Impact factor: 3.112

4.  Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis.

Authors:  Gabriel Grimaldi; Antonio Teva; Adelson L Ferreira; Claudiney B dos Santos; Israel de-Souza Pinto; Carolina T de-Azevedo; Aloísio Falqueto
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-01       Impact factor: 2.184

5.  Competence of the human host as a reservoir for Leishmania chagasi.

Authors:  C H Costa; R B Gomes; M R Silva; L M Garcez; P K Ramos; R S Santos; J J Shaw; J R David; J H Maguire
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

6.  Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.

Authors:  Renato Porrozzi; Marcos V Santos da Costa; Antonio Teva; Aloísio Falqueto; Adelson L Ferreira; Claudiney D dos Santos; Ana Paula Fernandes; Ricardo T Gazzinelli; Antonio Campos-Neto; Gabriel Grimaldi
Journal:  Clin Vaccine Immunol       Date:  2007-02-21

7.  Cross-sectional and longitudinal epidemiologic surveys of human and canine Leishmania infantum visceral infections in an endemic rural area of southeast Brazil (Pancas, Espirito Santo).

Authors:  Aloísio Falqueto; Adelson L Ferreira; Claudiney B dos Santos; Renato Porrozzi; Marcos V Santos da Costa; Antonio Teva; Elisa Cupolillo; Antonio Campos-Neto; Gabriel Grimaldi
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

8.  Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies.

Authors:  Erika Monteiro Michalsky; Marília Fonseca Rocha; Ana Cristina Vianna Mariano da Rocha Lima; João Carlos França-Silva; Marize Quinhone Pires; Fernanda Santos Oliveira; Raquel Silva Pacheco; Sara Lopes dos Santos; Ricardo Andrade Barata; Alvaro José Romanha; Consuelo Latorre Fortes-Dias; Edelberto Santos Dias
Journal:  Vet Parasitol       Date:  2007-04-20       Impact factor: 2.738

9.  Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil.

Authors:  Cáris Maroni Nunes; Valéria Marçal Félix de Lima; Henrique Borges de Paula; Silvia Helena Venturoli Perri; Andréa Maria de Andrade; Francisca Elda Ferreira Dias; Marcelo Nascimento Burattini
Journal:  Vet Parasitol       Date:  2008-01-17       Impact factor: 2.738

Review 10.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19
View more
  8 in total

1.  Evaluation of conjunctival swab as a mass-screening tool for molecular diagnosis of canine visceral leishmaniasis.

Authors:  Rodrigo Souza Leite; Natalia Alves Souza; Amanda Duarte Barbosa; Aline Leandra Carvalho Ferreira; Antero Silva Ribeiro de Andrade
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

2.  Risk factors for seroconversion by Leishmania infantum in a cohort of dogs from an endemic area of Brazil.

Authors:  Wendel Coura-Vital; Alexandre Barbosa Reis; Maria Arlene Fausto; Gleisiane Gomes de Almeida Leal; Marcos José Marques; Vanja Maria Veloso; Mariângela Carneiro
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

3.  Evaluation of change in canine diagnosis protocol adopted by the visceral leishmaniasis control program in Brazil and a new proposal for diagnosis.

Authors:  Wendel Coura-Vital; Henrique Gama Ker; Bruno Mendes Roatt; Rodrigo Dian Oliveira Aguiar-Soares; Gleisiane Gomes de Almeida Leal; Nádia das Dores Moreira; Laser Antônio Machado Oliveira; Evandro Marques de Menezes Machado; Maria Helena Franco Morais; Rodrigo Corrêa-Oliveira; Mariângela Carneiro; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 4.  Wild and synanthropic reservoirs of Leishmania species in the Americas.

Authors:  André Luiz R Roque; Ana Maria Jansen
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-08-29       Impact factor: 2.674

5.  Effectiveness of insecticide spraying and culling of dogs on the incidence of Leishmania infantum infection in humans: a cluster randomized trial in Teresina, Brazil.

Authors:  Guilherme L Werneck; Carlos H N Costa; Fernando Aécio Amorim de Carvalho; Maria do Socorro Pires e Cruz; James H Maguire; Marcia C Castro
Journal:  PLoS Negl Trop Dis       Date:  2014-10-30

6.  The performance of serological tests for Leishmania infantum infection screening in dogs depends on the prevalence of the disease.

Authors:  Ivete Lopes de Mendonça; Joilson Ferreira Batista; Henk Schallig; Maria do Socorro Pires E Cruz; Diego Peres Alonso; Paulo Eduardo Martins Ribolla; Dorcas Lamounier Costa; Carlos Henrique Nery Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-06-01       Impact factor: 1.846

7.  Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.

Authors:  Gabriel Grimaldi; Antonio Teva; Claudiney B Dos-Santos; Fernanda Nunes Santos; Israel de-Souza Pinto; Blima Fux; Gustavo Rocha Leite; Aloísio Falqueto
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

Review 8.  Low quality evidence of epidemiological observational studies on leishmaniasis in Brazil.

Authors:  Bruno Trentini; Mário Steindel; Mariel A Marlow
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.